Celera Registration Statement Declared Effective; Split with ABI Expected on July 1 | GenomeWeb
NEW YORK (GenomeWeb News) – Celera’s registration statement with the US Securities and Exchange Commission was declared effective yesterday by the regulatory body, clearing the way for Celera’s formal separation from sister company Applied Biosystems and parent firm Applera.
 
The split will take place at 12:01 a.m. EDT, on July 1, subject to certain conditions, including receipt of certain contents and listing of Celera’s stock on the Nasdaq, according to an Applera statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.